⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 4, 2025

Supplementary Figure S2 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation

Fangqi Hu Song Zhang Jie Chai

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: METTL3 promotes gastric cancer progression through modulation of signaling pathways.
KEY EVIDENCE: The study found that METTL3 affects FNTA, resulting in enhanced KRAS/ERK signaling activation.
APPROACH: Quantification analysis was used to assess the modulation of signaling components related to gastric cancer.
SIGNIFICANCE: Understanding METTL3's role in cancer can contribute to better-targeted therapies for gastric cancer.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Quantification analysis shows mettl3 modulates fnta to activate kras/erk signaling in gastric cancer, implying a role in disease progression.

Abstract

Quantification analysis

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d0988 https://doi.org/10.1158/1541-7786.29819560

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation2025
2Supplementary Figure S1 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation2025
3Data from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation2025
4Supplementary Figure S9 from TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression2025
5Supplementary Figure S4 from TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression2025
6Supplementary Figure S8 from TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression2025
7Figure S3 from Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells2024
8Figure S2 from Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells2024